# Furiex Pharmaceuticals, Inc.

Furiex Pharmaceuticals, Inc. is a company headquartered in Morrisville, NC, United States.

## Company overview

- **Legal name:** Furiex Pharmaceuticals, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Morrisville, NC, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001484478

## About

Furiex Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001484478, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2014-03-17, it reported annual revenue of USD 70,999,000; net income of USD -29,673,000; total assets of USD 88,442,000 for the fiscal period ended 2013-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2013 (period ended 2013-12-31)

- **Revenue:** $71.0M (USD 70,999,000)
- **Net income:** -$29.7M (USD -29,673,000)
- **Total assets:** $88.4M (USD 88,442,000)
- **Cash and equivalents:** $29.2M (USD 29,153,000)
- **Operating cash flow:** -$23.1M (USD -23,139,000)

### FY2012 (period ended 2012-12-31)

- **Revenue:** $40.5M (USD 40,508,000)
- **Net income:** -$42.9M (USD -42,865,000)
- **Total assets:** $94.8M (USD 94,755,000)
- **Cash and equivalents:** $25.7M (USD 25,718,000)
- **Operating cash flow:** -$40.6M (USD -40,633,000)

### FY2011 (period ended 2011-12-31)

- **Revenue:** $4.5M (USD 4,490,000)
- **Net income:** -$49.0M (USD -48,981,000)
- **Total assets:** $95.1M (USD 95,124,000)
- **Cash and equivalents:** $33.6M (USD 33,628,000)
- **Operating cash flow:** -$49.0M (USD -49,000,000)

## Recent SEC filings

- Form SC 13D — filed 2014-07-07 — SC 13D
- Form 8-K — filed 2014-07-03 — period 2014-07-01 — FORM 8-K
- Form 8-K — filed 2014-07-01 — period 2014-07-01 — FORM 8-K
- Form SC 13D — filed 2014-06-16 — SCHEDULE 13D
- Form 8-K — filed 2014-05-28 — period 2014-05-22 — FORM 8-K
- Form 10-Q — filed 2014-05-09 — period 2014-03-31 — FORM 10-Q
- Form SC 13G — filed 2014-05-09 — MS INITIAL
- Form 8-K — filed 2014-05-07 — period 2014-05-06 — FORM 8-K
- Form SC 13D — filed 2014-05-06 — SCHEDULE 13D
- Form 8-K — filed 2014-04-29 — period 2014-04-27 — 8-K
- Form DEF 14A — filed 2014-04-11 — period 2014-05-22 — FORM DEF 14A
- Form 10-K — filed 2014-03-17 — period 2013-12-31 — FORM 10-K

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/furiex-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology